The Kennedy Trust

The trust founded the Kennedy Institute of Rheumatology at the University of Oxford, which serves as its principal research partner. The institute operates as an academic unit within the university but was established through a major grant from the trust in the 1960s, and the two entities continue to collaborate closely on rheumatology research funding and scientific direction.

The trust holds a diversified portfolio that includes direct UK commercial real estate exposures — confirmed positions include the Savills Charity Property Fund, Mayfair PITCH, and the CCLA COIF Charities Property Fund. It also allocates to growth equities and managed strategies, though specific public-market holdings are not disclosed. The investment approach is overseen directly by its board of trustees rather than outsourced to an OCIO.

No. The trust's grant-making mandate is concentrated exclusively on rheumatology and related musculoskeletal diseases, consistent with its mission since 1965. Its funding flows primarily to UK-based researchers and institutions, with the Kennedy Institute of Rheumatology at Oxford as the flagship recipient.

The trust's board of trustees governs investment decisions. Joe Cronly, a trustee with a private equity background, is the named investment specialist on the board. The trust does not disclose a dedicated in-house chief investment officer, suggesting a trustee-led investment committee structure rather than a hired investment team.

Versus Arthritis, the UK's largest arthritis research charity, is a frequent co-funder of rheumatology research initiatives alongside the trust. The two organizations share a funding ecosystem focused on UK-based musculoskeletal research, but they remain operationally independent entities with separate endowments and governance.

No. The trust does not manage third-party capital or operate co-investment vehicles. It functions exclusively as an endowed charitable trust deploying its own corpus. Its co-funding of research with organizations like Versus Arthritis is grant-based collaboration, not shared investment activity.

The endowment derives from the personal wealth of Mathilda Kennedy, the daughter of Michael Marks, who co-founded the Marks & Spencer retail chain in 1884. The trust was capitalized at its founding in 1965 and has since operated as a self-sustaining charitable asset manager, funding its grants entirely from investment returns on that original corpus.